Abstract:
:The risks of cancers other than breast and ovarian amongst BRCA1 and BRCA2 mutation carriers are based on relatively few family based studies with the risk of specific cancers tested in population based samples of cancers from founder populations. We assessed risks of "other cancers" in 268 BRCA1 families and 222 BRCA2 families using a person years at risk analysis from 1975 to 2005. Cancer confirmations were overall higher than in previous family based studies at 64%. There was no overall increase in risk for BRCA1 carriers although oesophagus had a significant increased RR of 2.9 (95% CI 1.1-6.0) and stomach at 2.4 (95% CI 1.2-4.3), these were based mainly on unconfirmed cases. For BRCA2 increased risks for cancers of the pancreas (RR 4.1, 95% CI 1.9-7.8) and prostate (RR 6.3, 95% CI 4.3-9.0) and uveal melanoma (RR 99.4, 95% CI 11.1-359.8) were confirmed. Possible new associations with oesophagus (RR 4.1, 95% CI 1.9-7.8) and stomach (RR 2.7, 95% CI 1.3-4.8) were detected but these findings should be treated with caution due to lower confirmation rates. In contrast to previous research a higher risk of prostate cancer was found in males with mutations in the BRCA2 OCCR region. The present study strengthens the known links between BRCA2 and pancreatic and prostate cancer, but throws further doubt onto any association with BRCA1. New associations with upper gastro-intestinal malignancy need to be treated with caution and confirmed by large prospective studies.
journal_name
Fam Cancerjournal_title
Familial cancerauthors
Moran A,O'Hara C,Khan S,Shack L,Woodward E,Maher ER,Lalloo F,Evans DGdoi
10.1007/s10689-011-9506-2subject
Has Abstractpub_date
2012-06-01 00:00:00pages
235-42issue
2eissn
1389-9600issn
1573-7292journal_volume
11pub_type
杂志文章相关文献
Familial Cancer文献大全abstract:PURPOSE:The aim of the present descriptive study was to investigate the experience of sharing genetic information among cancer genetic counselees and their at-risk relatives. METHODS:In total, 147 cancer genetic counselees and 81 of their at-risk relatives answered to a study specific questionnaire and/or were intervi...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-010-9364-3
更新日期:2010-12-01 00:00:00
abstract::Description of the various modalities of breast and ovarian cancer risk management, patient choices and their outcome in a single-center cohort of 158 unaffected women carrying a BRCA1 or BRCA2 germline mutation. Between 1998 and 2009, 158 unaffected women carrying a BRCA1 or BRCA2 gene mutation were prospectively fol...
journal_title:Familial cancer
pub_type: 临床试验,杂志文章
doi:10.1007/s10689-012-9539-1
更新日期:2012-09-01 00:00:00
abstract::We assessed mismatch repair by immunohistochemistry (IHC) and microsatellite instability (MSI) analysis in an early onset endometrial cancer and a sister's colon cancer. We demonstrated high-level MSI and normal expression for MLH1, MSH2 and MSH6. PMS2 failed to stain in both tumors, strongly implicating a PMS2 defect...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-009-9276-2
更新日期:2009-01-01 00:00:00
abstract::In the absence of a polyposis phenotype, colorectal cancer (CRC) patients referred for genetic testing because of early-onset disease and/or a positive family history, typically undergo testing for molecular signs of Lynch syndrome in their tumors. In the absence of these signs, DNA testing for germline mutations asso...
journal_title:Familial cancer
pub_type: 杂志文章,评审
doi:10.1007/s10689-012-9570-2
更新日期:2013-03-01 00:00:00
abstract::CAPP1 tested aspirin 600 mg/day and/or resistant starch 30 g/day in 200 adolescent FAP carriers. Aspirin treatment resulted in a non-significant reduction in polyp number and a significant reduction in polyp size among patients treated with aspirin for more than 1 year. CAPP2 RCT used the same interventions in 937 Lyn...
journal_title:Familial cancer
pub_type: 杂志文章,多中心研究,随机对照试验
doi:10.1007/s10689-013-9650-y
更新日期:2013-12-01 00:00:00
abstract::We recently described a novel g.8097_22733del14637 deletion encompassing exons 3-5 in BRCA1 gene. This rearrangement was detected in 3 of 15 (20 %) breast and/or ovarian cancer families of Eastern Spain. This finding made us suspect that the newly identified deletion could be a founder mutation. To confirm this hypoth...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-012-9579-6
更新日期:2013-03-01 00:00:00
abstract::Women with a family history of breast cancer who are diagnosed with breast cancer are often counseled to undergo prophylactic mastectomy as part of their treatment for breast cancer. The majority of such individuals make these decisions in haste and without appropriate genetic counseling or testing. Most of them when ...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-007-9167-3
更新日期:2008-01-01 00:00:00
abstract::Distress levels among female BRCA1/2 mutation carriers can be similar to levels found among breast cancer patients. While psychological distress has been associated with unmet needs among cancer patients no study has examined this among BRCA1/2 mutation carriers. The objectives of this study were to: (1) describe the ...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-012-9596-5
更新日期:2013-09-01 00:00:00
abstract::Lynch Syndrome is caused by mutations in DNA mismatch repair genes. Diagnosis is not always trivial and may be costly. Information regarding incidence, genotype-phenotype correlation, spectrum of mutations and genes involved in specific populations facilitate the diagnostic process and contribute to clinical work-up. ...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-013-9675-2
更新日期:2014-03-01 00:00:00
abstract::The initial enthusiasm generated by the discovery of the first susceptibility gene found for melanoma has slightly dampened over recent years. For the majority of melanoma families the underlying gene defect is still not known, so the search for other melanoma genes is continuing. Also, the increased risk of melanoma ...
journal_title:Familial cancer
pub_type: 杂志文章,评审
doi:10.1023/a:1025758527675
更新日期:2003-01-01 00:00:00
abstract::New Zealand Māori have a considerably higher incidence of gastric cancer compared to non-Māori, and are one of the few populations worldwide with a higher prevalence of diffuse-type disease. Pathogenic germline CDH1 mutations are causative of hereditary diffuse gastric cancer, a cancer predisposition syndrome primaril...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-018-0080-8
更新日期:2019-01-01 00:00:00
abstract::Cowden syndrome (CS) is a cancer predisposition syndrome caused by germline mutations in the PTEN tumor suppressor gene. It is associated with an increased risk of thyroid, breast and endometrial cancer but many manifestations can be found in the head and neck region, some of which are pathognomonic. Here we report a ...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-011-9472-8
更新日期:2011-12-01 00:00:00
abstract::This study was aimed to characterize the distribution of colorectal cancer risk using family history of cancers by data mining. Family histories for 10,066 colorectal cancer cases recruited to population cancer registries of the Colon Cancer Family Registry were analyzed using a data mining framework. A novel index wa...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-015-9860-6
更新日期:2016-04-01 00:00:00
abstract::This is an 11-year survey of molecular analysis of APC germline mutations for the province of Quebec done at the Molecular Pathology Unit of the Jewish General Hospital which offers genetic testing for hereditary forms of colorectal cancer for the whole of Quebec province. We report on 47 unique mutations seen in 66 f...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-011-9468-4
更新日期:2011-12-01 00:00:00
abstract::Hereditary nonpolyposis colorectal cancer (HNPCC) is primarily linked to colorectal and endometrial cancer, but is associated with a broad tumor spectrum. Though not formally part of the syndrome, occasional sarcomas have been reported in individuals with HNPCC. We used the national Danish HNPCC-register to identify H...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-008-9230-8
更新日期:2009-01-01 00:00:00
abstract::African-American women are more likely to develop aggressive breast cancer at younger ages and experience poorer cancer prognoses than non-Hispanic Caucasians. Deficiency in repair of DNA by homologous recombination (HR) is associated with cancer development, suggesting that mutations in genes that affect this process...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-017-0036-4
更新日期:2018-04-01 00:00:00
abstract::A new BRCA1 locus product called BRCA1-IRIS has been identified recently. High-risk breast/ovarian families have not been screened for germ-line mutations at the specific BRCA1-IRIS coding sequence, as it was considered merely as part of BRCA1 intron 11. Here we report the first comprehensive screening of germ-line mu...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-005-1236-x
更新日期:2005-01-01 00:00:00
abstract::While a dominant inheritance of breast cancer (vertical inheritance) is well known, less is known about a possible recessive inheritance (horizontal inheritance). In a clinical series of 1676 breast cancer patient's family history was scored as vertical (grandmother-aunt-mother-sister-daughter) or horizontal (sister-s...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-010-9355-4
更新日期:2010-12-01 00:00:00
abstract::Peutz-Jeghers syndrome (PJS) is a hereditary polyposis syndrome characterized by hamartomatous Peutz-Jeghers polyps in the gastrointestinal tract, mucocutaneous pigmentations, and increased risk for intestinal and extraintestinal cancer. In more than two-third of patients it is possible to detect pathogenic variants i...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-020-00191-4
更新日期:2020-06-06 00:00:00
abstract::Family history of melanoma is a major melanoma risk factor. However, self-reported family histories for some cancers, including melanoma, are commonly inaccurate. We used a unique database, the Utah Population Database (UPDB), as well as the Utah Cancer Registry to determine the accuracy of self-reported family histor...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-020-00187-0
更新日期:2020-05-21 00:00:00
abstract::Possession of a BRCA1/2 mutation increases risk of contralateral breast and ovarian cancer recurrence and may have an impact on health management decisions, such as imaging screening, preventive surgical interventions and systemic therapies. A hospital-based study was conducted to assess the frequency and spectrum of ...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-012-9560-4
更新日期:2012-12-01 00:00:00
abstract::Microsatellite instability (MSI) testing is useful for identifying patients with hereditary nonpolyposis colorectal cancer and detecting sporadic colorectal cancer that develops through replication error pathways. A pentaplex panel is recommended by the National Cancer Institute for MSI testing, but simplified mononuc...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-012-9536-4
更新日期:2012-09-01 00:00:00
abstract::Increased risk for urological tumors has been observed in mutation carriers with Lynch syndrome (LS). In this study, we evaluated the clinical features of uroepithelial (bladder and ureter) and kidney cancers in 974 Finnish mutation carriers. Altogether 30 patients had a total of 34 urological tumors: 12 ureter, 12 bl...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-012-9526-6
更新日期:2012-09-01 00:00:00
abstract::The succinate dehydrogenase (SDH) is a mitochondrial enzyme complex with an important role in oxydative phosphorylation and intracellular oxygene sensing and signaling. Mutations in the SDHB (1p35-36) and SDHD subunits (11q23) give rise to the paraganglioma syndromes (PGL), namely PGL 4 and PGL 1, and generate paragan...
journal_title:Familial cancer
pub_type: 杂志文章,评审
doi:10.1007/s10689-004-4227-4
更新日期:2005-01-01 00:00:00
abstract::Hereditary non-polyposis colorectal cancer (HNPCC) is one of the most common forms of hereditary colorectal cancer. It is an autosomal dominant disorder resulting from germline mutations in DNA mismatch repair genes. In this study, we screened hMLH1 gene in a group of Iranian HNPCC patients using polymerase chain reac...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-011-9478-2
更新日期:2012-03-01 00:00:00
abstract::Li-Fraumeni syndrome (LFS) is a dominantly inherited cancer predisposition syndrome characterized by a wide spectrum of neoplasms occurring at young age. Germline mutations in the TP53 tumor suppressor gene have been identified in approximately 71 of LFS patients and 22 of Li-Fraumeni-like (LFL) patients. Mutations wi...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-004-1946-5
更新日期:2005-01-01 00:00:00
abstract::To support persons having a genetic predisposition to cancer and their partners during reproductive decision-making, an online decision aid was developed and evaluated. To maximize the impact of the support tool, this mixed methods study aims at developing the optimal implementation strategy for the decision aid. A qu...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-019-00119-7
更新日期:2019-04-01 00:00:00
abstract::Nogo proteins play an important role in the apoptosis of cells, especially in tumor cells. The present study was conducted to evaluate whether the TATC (rs71682980) and CAA (rs34917480) insertion/deletion polymorphisms of RTN4 3'-UTR are associated with clear cell renal cell carcinoma (ccRCC). These two polymorphisms ...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-017-0005-y
更新日期:2018-01-01 00:00:00
abstract:BACKGROUND:Colorectal cancers resulting from defective DNA mismatch repair can occur in both hereditary non-polyposis colon cancer (HNPCC) and in the sporadic setting. They are characterised by a high level of microsatellite instability (MSI-H) and superficially resemble each other in that they are frequently located i...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1023/B:FAME.0000039861.30651.c8
更新日期:2004-01-01 00:00:00
abstract::Pathological features and consequently, tumor response differ between BRCA1/2 carriers and sporadic breast cancer (BC) cases. It is expected that BRCA1/2 associated tumors will be more vulnerable to DNA damaging agents and irradiation due to their function in DNA repair. In addition, very high pathological complete re...
journal_title:Familial cancer
pub_type: 杂志文章
doi:10.1007/s10689-008-9223-7
更新日期:2009-01-01 00:00:00